ICONICITY ADAPTATION: AN ANALYSIS OF ONOMATOPOEIAS IN FINANCE SMURFS COMIC AND ITS INDONESIAN TRANSLATION SMURF BENDAHARA
LITE: Jurnal Bahasa, Sastra, dan Budaya · 2020
DOI: 10.33633/lite.v16i1.3487 ↗Kurz gefasst
Fachartikel in der Zeitschrift LITE: Jurnal Bahasa, Sastra, dan Budaya, 2020. Verfasst von Ailsa Agatha Santoso und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Onomatopoeia is one example of iconic signs influenced by the culture of the origin of the speakers. Translating an onomatopoeic word will need more than just a dictionary, but also culture and linguistic understanding of both source and target languages. Dealing with this issue, this research attempts to investigate how the onomatopoeias featured in the Finance Smurfs comic is translated into Indonesian. The data were obtained from Finance Smurfs comic and its translated version. Using articulatory phonetics to describe 47 onomatopoeias found in the comic, 43 are classified as iconic in both SL and TL, while 4 of them are not iconic. In addition, although the forms of onomatopoeias in source and target language are different their meanings are maintained based on the context.
Zitieren
APA
Santoso, A. A., & Setyaningsih, N. (2020). ICONICITY ADAPTATION: AN ANALYSIS OF ONOMATOPOEIAS IN FINANCE SMURFS COMIC AND ITS INDONESIAN TRANSLATION SMURF BENDAHARA. LITE: Jurnal Bahasa, Sastra, dan Budaya. https://doi.org/10.33633/lite.v16i1.3487
Vancouver
Santoso AA, Setyaningsih N. ICONICITY ADAPTATION: AN ANALYSIS OF ONOMATOPOEIAS IN FINANCE SMURFS COMIC AND ITS INDONESIAN TRANSLATION SMURF BENDAHARA. LITE: Jurnal Bahasa, Sastra, dan Budaya. 2020. doi:10.33633/lite.v16i1.3487
BibTeX
@article{Santoso2020,
author = {Santoso, Ailsa Agatha and Setyaningsih, Nina},
title = {ICONICITY ADAPTATION: AN ANALYSIS OF ONOMATOPOEIAS IN FINANCE SMURFS COMIC AND ITS INDONESIAN TRANSLATION SMURF BENDAHARA},
journal = {LITE: Jurnal Bahasa, Sastra, dan Budaya},
year = {2020},
doi = {10.33633/lite.v16i1.3487}
}
EUVIMED